Making progress for how medicines are used in children [1]

Archives of Pediatrics and Adolescent Medicine

Volumn 161, Issue 9, 2007, Pages 916-

  Taylor Zapata, Perdita ^a   Mattison, Donald R ^b  

^a Obstetric and Pediatric Pharmacology Branch   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; DACTINOMYCIN; DAUNORUBICIN; HYDROXYUREA; KETAMINE; LITHIUM; LORAZEPAM; METHOTREXATE; METHYLPHENIDATE; MORPHINE; NITROPRUSSIDE SODIUM; VINCRISTINE;

CHILD CARE; CHILDHOOD CANCER; CONSULTATION; DRUG INDUSTRY; DRUG USE; EPILEPTIC STATE; FOOD AND DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; LETTER; MANIA; MEDICINE; PAIN; PRESCRIPTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SPASTICITY;

EID: 34548429596     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.161.9.916-a     Document Type: Letter

References (4)

1. Shah SS, Hall M, Goodman DM. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3):282-290.
2. Giacoia GP, Birenbaum DL, Sachs HC, Mattison DR. The newborn drug development initiative. Pediatrics. 2006;117(3, pt 2):S1-S8.
3. Giacoia G, Taylor-Zapata P, Mattison D. Need for appropriate formulations for children: The National Institute of Child Health and Human Development - Pediatric Formulations Initiative, Part 1. Int J Pharm Compounding. 2007;11(1):5-8.
4. Nelson RM. Challenges in the conduct of emergency research in children: a workshop report. Am J Bioeth. 2006;6(6):W1-W9.